Matthias Matter to Immunotherapy
This is a "connection" page, showing publications Matthias Matter has written about Immunotherapy.
Connection Strength
0.075
-
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX). Target Oncol. 2019 10; 14(5):577-590.
Score: 0.075